cromolyn sodium has been researched along with Cirrhosis, Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, EY; Choi, JS; Choi, JW; Kim, JK; Kim, P; Kim, Y; Lee, DH; Park, SG; Yang, YJ | 1 |
1 other study(ies) available for cromolyn sodium and Cirrhosis, Liver
| Article | Year |
|---|---|
Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells.
Topics: Apoptosis; Cells, Cultured; Cellular Senescence; Collagen; Cromolyn Sodium; Epithelial-Mesenchymal Transition; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Transforming Growth Factor beta | 2015 |